| First Author | Meyer LH | Year | 2011 |
| Journal | Cancer Res | Volume | 71 |
| Issue | 23 | Pages | 7141-4 |
| PubMed ID | 22088964 | Mgi Jnum | J:178609 |
| Mgi Id | MGI:5299362 | Doi | 10.1158/0008-5472.CAN-11-1732 |
| Citation | Meyer LH, et al. (2011) Diversity of human leukemia xenograft mouse models: implications for disease biology. Cancer Res 71(23):7141-4 |
| abstractText | Over the past decade, xenografting human leukemia cells into mice with different levels of immunodeficiency, with or without preconditioning, has provided an important tool to study various aspects of leukemia biology and to identify distinct clinical risk groups for evaluation of novel therapeutic strategies, as well as the possibility of amplifying human leukemia cells in vivo. Interestingly, these models using human acute lymphoblastic leukemia and acute myeloid leukemia cells as xenografts recapitulate many clinical features of the disease. Similar to the human environment (for example, in the bone marrow), transplanted leukemia cells in the murine setting are exposed to both favorable and unfavorable conditions for engraftment that may exert a distinct pressure for selection of subclones. Thus, results obtained in these models may vary depending on the experimental setup. The impact of in vivo growth of human leukemia cells on the background of a more or less hostile murine environment for leukemia biology and the course of the disease in patients are discussed in the context of the diversity of xenograft models. Cancer Res; 71(23); 7141-4. (c)2011 AACR. |
